Stay updated with breaking news from Strides Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Puri, who led HDFC Bank since its inception over 25 years ago, retired in October 2020, after a highly successful career which has made the bank the largest among private sector lenders.
Read more about TCS, Biocon, Bharat Rasayan in focus on Business Standard. Tata Consultancy Services (TCS) will declare its December 2020 quarter earnings today, 8 January 2021.
-kiyD--621x414@LiveMint_1610073667536.JPG)
Stocks to Watch: TCS, Biocon, Tata Power, Union Bank, DHFL, HCL Tech Premium Share Via Read Full Story NEW DELHI : Here’s a list of top ten stocks that may be in news on Friday: TCS: The IT firm will announce its earnings for the quarter ended 31 December today. Tata Consultancy Services is expected to sustain the revenue momentum in Q3FY21 following an uptick in business activities. TRENDING STORIESSee All 1 min read Premium 1 min read Premium 1 min read Premium 1 min read . 08:41 AM IST Biocon Limited: Biocon Biologics Ltd, a subsidiary of Biocon Ltd, has approved a primary equity inve...
Former HDFC Bank MD Aditya Puri joins biopharma company Strides as advisor Aditya Puri said that he was looking forward to working with Kumar and building world-class institutions to produce high-quality affordable biotherapeutics and CDMO services BusinessToday.In | January 8, 2021 | Updated 13:51 IST Aditya Puri joins biopharma group as advisor Former HDFC Bank Managing Director Aditya Puri has joined Strides Group as Advisor and Stelis Biopharma Bengaluru as Director. "Strides Pharma Science Limited is pleased to announce that eminent corporate doyen Aditya Puri joins the Strides Group as...
Former HDFC Bank managing director Aditya Puri has joined global pharma major Strides Group as an advisor and will also serve as a director of its associate company Stelis Biopharma. "Eminent corporate doyen Aditya Puri joins the Strides Group as an advisor and also will be a director of its associate company, Stelis Biopharma," Strides Pharma Science Ltd said in a regulatory filing. Strides Pharma Science said Puri's appointment to the Stelis board comes at an exciting juncture for the company as it transitions from its incubation phase to a consolidation and growth phase to establish itse...